Dengue clinches Takeda deal

被引：0
|
作者：
Aaron Bouchie
机构：
来源：
Nature Biotechnology | 2013年 / 31卷 / 8期
关键词：
D O I：
10.1038/nbt0813-667
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：667 / 667
相关论文
共 50 条
  • [21] PHARMACEUTICALS GSK clinches $3.6 billion deal for Human Genome Sciences
    Mullin, Rick
    [J]. CHEMICAL & ENGINEERING NEWS, 2012, 90 (30) : 7 - 7
  • [22] ASW Cardiff clinches steel deal as Sheerness plant faces the axe
    不详
    [J]. PROFESSIONAL ENGINEERING, 2002, 15 (22) : 4 - 4
  • [23] PROGRESS IN DEVELOPMENT OF TAKEDA'S TETRAVALENT DENGUE VACCINE CANDIDATE
    Tricou, Vianney
    Saez-Llorens, Xavier
    Yu, Delia
    Rivera, Luis
    Borkowski, Astrid
    Wallace, Derek
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 194 - 194
  • [24] South Korean firm clinches Great Man-made River deal
    [J]. OPEC Bulletin, 2000, 31 (03):
  • [25] Moving forward with Takeda's live chimeric tetravalent dengue vaccine
    Wilder-Smith, Annelies
    [J]. LANCET INFECTIOUS DISEASES, 2017, 17 (06): : 566 - 568
  • [26] Schlumberger to acquire Sema, takes over PCSI, clinches Bull CP 8 deal
    [J]. Card Technology Today, 2001, 13 (03)
  • [27] Takeda's Largest Study Brings Dengue Vaccine Step Closer
    Hirschler, Ben
    [J]. CLINICAL INFECTIOUS DISEASES, 2017, 65 (01) : II - II
  • [28] R&D - Air Products clinches DoE ionic ceramic membrane deal
    不详
    [J]. EUROPEAN CHEMICAL NEWS, 1997, 67 (1767): : 24 - 24
  • [29] Analysis of T Cell Immunity Generated by Takeda's Tetravalent Dengue Vaccine
    Omidi, Nazanin
    Victor, Kaitlin
    Gray, Lauren
    Nadeem, Iqra
    Bolton, Jessica
    Robinson, Tanisha
    Hatch, Kristin
    Sharma, Mayuri
    Mandaric, Sanja
    Tricou, Vianney
    Currier, Jeffrey
    Friberg, Heather
    [J]. JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [30] Undeterred by Sanofi's Stumble, Takeda Takes Similar Path With Dengue Shot
    Kaye, Donald
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 68 (09) : I - II
12345